Latest ECTRIMS News
S1P Receptor Modulator May Boost Cognitive Processing Speed in Early MS
Treatment with ozanimod (Zeposia) led to clinically meaningful improvement in cognitive processing…
BTK Inhibitor Reduces Brain Lesions in Relapsing MS
MILAN -- Investigational fenebrutinib reduced brain lesions in relapsing multiple sclerosis (MS)…
Neurofilament Light Predicts MS Worsening in Silent Progression
Neuroaxonal pathology occurred in advance of -- not coincident with -- clinical…
Path to Multiple Sclerosis Cure on the Horizon
MILAN -- A path to a cure for multiple sclerosis (MS) may…
Subcutaneous Ocrelizumab Not Inferior to IV Infusion
MILAN -- An investigational 10-minute subcutaneous injection of ocrelizumab (Ocrevus) was non-inferior…
Novel Drug Shows Promise in Multiple Sclerosis
MILAN -- Treatment with investigational frexalimab, a novel CD40 ligand (CD40L) inhibitor,…
